The UK Register of HIV Seroconverters: methods and analytical issues

A Register of HIV-infected persons who have had a negative antibody test within 3 years of their first antibody positive test (seroconverters) is being set up in the UK to monitor the distribution of times from HIV seroconversion to AIDS (the incubation period) and to death. It will also provide a national resource for use by those designing studies in this group of individuals. Clinicians caring for HIV-positive persons in Genito-Urinary Medicine, Infectious Disease and other departments throughout the UK were asked to participate by providing information on eligible subjects. Most laboratories undertaking HIV antibody testing were also contacted and asked to provide the name of the attending clinician for all seroconverters identified through the HIV laboratory reporting systems of the PHLS Communicable Disease Surveillance Centre (CDSC) and the Scottish Centre for Infection and Environmental Health (SCIEH) and for any other seroconverters known to them but not identified by CDSC or SCIEH. Data items sought for the Register include: sex, ethnic group, probable route of HIV transmission, annual CD4 counts, details of therapy and prophylaxis prescribed, AIDS-defining events and vital status. Follow up information is collected annually. Wherever possible, all seroconverters known to a clinic have been identified, whether currently alive or dead, either from clinic records or laboratory reporting or both. The objective is to establish and update a complete register of seroconverters on a long-term to basis to provide reliable estimates of the incubation period on which future projections of AIDS cases in the UK can be made.

[1]  Giovanni Rezza,et al.  HIV disease progression in 854 women and men infected through injecting drug use and heterosexual sex and followed for up to nine years from seroconversion , 1994, BMJ.

[2]  R Bellocco,et al.  Median time from seroconversion to AIDS in Italian HIV-positive haemophiliacs: different parametric estimates. , 1994, Statistics in medicine.

[3]  G. Rutherford,et al.  The natural history of transfusion-associated infection with human immunodeficiency virus. Factors influencing the rate of progression to disease. , 1989, The New England journal of medicine.

[4]  J. Kaldor,et al.  Long-term symptomless HIV-1 infection in recipients of blood products from a single donor , 1992, The Lancet.

[5]  Estimating the AIDS incubation period from a prevalent cohort. , 1991, American journal of epidemiology.

[6]  N. Dubin,et al.  CD4% is the best predictor of development of AIDS in a cohort of HIV‐infected homosexual men , 1991, AIDS.

[7]  J. Margolick,et al.  Changes in T-lymphocyte subsets in intravenous drug users with HIV-1 infection. , 1992, JAMA.

[8]  J. Phair,et al.  Trends in the incidence of outcomes defining acquired immunodeficiency syndrome (AIDS) in the Multicenter AIDS Cohort Study: 1985-1991. , 1993, American journal of epidemiology.

[9]  G. Rutherford,et al.  Prevalence, incidence, and progression of human immunodeficiency virus infection in homosexual and bisexual men in hepatitis B vaccine trials, 1978-1988. , 1989, American journal of epidemiology.

[10]  James J. Goedert,et al.  Effect of age at seroconversion on the natural AIDS incubation distribution , 1994, AIDS.

[11]  R. Doll,et al.  Incidence of AIDS and excess of mortality associated with HIV in haemophiliacs in the United Kingdom: report on behalf of the directors of haemophilia centres in the United Kingdom. , 1989, BMJ.

[12]  P. Krijnen,et al.  Predictors of rapid progression to AIDS in HIV-1 seroconverters. , 1993, AIDS.

[13]  A. Blaxhult,et al.  The influence of age on the latency period to AIDS in people infected by HIV through blood transfusion. , 1990, AIDS.

[14]  A Muñoz,et al.  Predictors of the risk of development of acquired immunodeficiency syndrome within 24 months among gay men seropositive for human immunodeficiency virus type 1: a report from the Multicenter AIDS Cohort Study. , 1992, American journal of epidemiology.

[15]  E. Scheibel,et al.  Clinical course of primary HIV infection: consequences for subsequent course of infection. , 1989, BMJ.

[16]  C. Sabin,et al.  Use of CD4 lymphocyte count to predict long term survival free of AIDS after HIV infection , 1994, BMJ.

[17]  Graham F. Medley,et al.  The treatment‐free incubation period of AIDS in a cohort of homosexual men , 1993, AIDS.

[18]  D. Cooper,et al.  Determinants of HIV disease progression among homosexual men registered in the Tricontinental Seroconverter Study. , 1994, American journal of epidemiology.

[19]  R. Park European AIDS definition , 1992, The Lancet.

[20]  S. Buchbinder,et al.  Progression of human immunodeficiency virus type 1 (HIV-1) infection among homosexual men in hepatitis B vaccine trial cohorts in Amsterdam, New York City, and San Francisco, 1978-1991. , 1994, American journal of epidemiology.

[21]  N. Jewell,et al.  Patterns of T lymphocyte changes with human immunodeficiency virus infection: from seroconversion to the development of AIDS. , 1989, Journal of acquired immune deficiency syndromes.

[22]  S. Brodine,et al.  CD4 lymphocyte counts within 24 months of human immunodeficiency virus seroconversion. Findings in the US Navy and Marine Corps. The Navy Retroviral Working Group. , 1993, Archives of internal medicine.